Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.

Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH.

Prev Med. 2010 May-Jun;50(5-6):297-9. doi: 10.1016/j.ypmed.2010.03.010. Epub 2010 Mar 20.

PMID:
20307568
3.
4.

Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).

Denis B, Gendre I, Aman F, Ribstein F, Maurin P, Perrin P.

Eur J Cancer. 2009 Dec;45(18):3282-90. doi: 10.1016/j.ejca.2009.06.015. Epub 2009 Aug 6.

PMID:
19665368
5.

Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.

Birkenfeld S, Belfer RG, Chared M, Vilkin A, Barchana M, Lifshitz I, Fruchter D, Aronski D, Balicer R, Niv Y, Levi Z.

J Med Screen. 2011;18(3):135-41. doi: 10.1258/jms.2011.010147.

PMID:
22045822
6.
7.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

PMID:
17895475
8.

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.

Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME.

Br J Cancer. 2009 Apr 7;100(7):1103-10. doi: 10.1038/sj.bjc.6604961.

9.

Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis.

Zhu MM, Xu XT, Nie F, Tong JL, Xiao SD, Ran ZH.

J Dig Dis. 2010 Jun;11(3):148-60. doi: 10.1111/j.1751-2980.2010.00430.x.

PMID:
20579218
10.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
11.

A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D.

J Natl Cancer Inst. 2004 May 19;96(10):770-80.

PMID:
15150305
12.

New stool screening tests for colorectal cancer.

Young GP, Cole S.

Digestion. 2007;76(1):26-33. Epub 2007 Oct 19. Review.

PMID:
17947816
13.

Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.

Tinmouth J, Lansdorp-Vogelaar I, Allison JE.

Gut. 2015 Aug;64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3. Review.

PMID:
26041750
14.

Measuring the quality of colorectal cancer screening: the importance of follow-up.

Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH, Parkerton PH, Asch SM.

Dis Colon Rectum. 2006 Jul;49(7):1002-10.

PMID:
16673056
15.
16.

Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.

Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD, Essink-Bot ML, Kuipers EJ.

Eur J Cancer. 2010 Jul;46(11):2059-66. doi: 10.1016/j.ejca.2010.03.022. Epub 2010 Jun 4.

PMID:
20621736
17.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
18.

A system-based intervention to improve colorectal cancer screening uptake.

Hoffman RM, Steel SR, Yee EF, Massie L, Schrader RM, Moffett ML, Murata GH.

Am J Manag Care. 2011 Jan;17(1):49-55.

19.

Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.

Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.

Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.

PMID:
22108194
20.

Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations.

Rabeneck L, Zwaal C, Goodman JH, Mai V, Zamkanei M.

Clin Biochem. 2008 Nov;41(16-17):1289-305. doi: 10.1016/j.clinbiochem.2008.08.069. Epub 2008 Aug 29.

PMID:
18796300

Supplemental Content

Support Center